0000899243-18-006100.txt : 20180302 0000899243-18-006100.hdr.sgml : 20180302 20180302161559 ACCESSION NUMBER: 0000899243-18-006100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180301 FILED AS OF DATE: 20180302 DATE AS OF CHANGE: 20180302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hooks Corwin Dale CENTRAL INDEX KEY: 0001665347 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 18662165 MAIL ADDRESS: STREET 1: C/O CLOVIS ONCOLOGY, INC. STREET 2: 5500 FLATIRON PARKWAY CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-01 0 0001466301 Clovis Oncology, Inc. CLVS 0001665347 Hooks Corwin Dale C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301 0 1 0 0 See Remarks Common Stock 2018-03-01 4 M 0 869 A 3556 D Common Stock 2018-03-01 4 F 0 467 55.51 D 3089 D Restricted Stock Units 2018-03-01 4 M 0 869 0.00 D Common Stock 869 8688 D Each Restricted Stock Unit represents the right to receive one share of Common Stock. On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date. Senior Vice President and Chief Commercial Officer /s/ Dale Corwin Hooks 2018-03-02